Available Forms: Tablets
Available Strengths: 54.5 mg, 18.2 mg , 36.3 mg,
Reference Brands: Exxua (USA)
Category: Neurology
Quick Response Guaranteed | Verified Suppliers
Product Description:
Gepirone hydrochloride, sold under the brand name Exxua, is an oral medication approved for the treatment of major depressive disorder (MDD) in adults. It belongs to the class of selective serotonin receptor partial agonists and works by modulating serotonergic neurotransmission in the brain, helping to alleviate depressive symptoms and improve mood. Gepirone’s mechanism of action involves partial stimulation of postsynaptic 5-HT1A receptors while modulating presynaptic autoreceptors, which enhances serotonin activity in key brain regions associated with mood regulation.
Clinical studies submitted to the U.S. Food and Drug Administration (FDA) included 15 trials evaluating gepirone for depression. Of these, two pivotal trials demonstrated significant effectiveness, showing that gepirone reduced depressive symptoms by approximately 2.5 points more than placebo on the 17-item Hamilton Depression Rating Scale (HAMD-17). These results were comparable to the effect sizes observed with other approved antidepressants, supporting its efficacy in adults with major depressive disorder. Exxua provides an additional treatment option for patients seeking effective management of depressive symptoms, particularly those who may benefit from its selective serotonergic activity.
Gepirone hydrochloride is used for the treatment of major depressive disorder and certain anxiety-related conditions.
Gepirone hydrochloride is a synthetic azapirone derivative formulated as an oral tablet.
The primary trade name of gepirone hydrochloride is Exxua.
Exxua is manufactured by Fabre-Kramer Pharmaceuticals in the USA, while clinical and research formulations are produced by various companies in other regions.
The generic name is gepirone hydrochloride.
The brand name is Exxua.
Gepirone hydrochloride tablets are manufactured in the USA and in countries with regulatory approval for its production and distribution.
Strength: 125 mg/mL, 200 mg, 250 mg, 300 mg, 500 mg, 100 mg/mL
Form: Tablet / Capsule/ Injection / Oral syrup
Reference Brands: Depakene (USA), Depakine (EU/LATAM), Valprol (India)
Strength: 50 mg, 100 mg
Form: Tablets
Reference Brands: Ubrelvy (USA/India)
Strength: 100 mg
Reference Brands: Tasmar (USA/EU)
Strength: 50 mg ,100 mg
Reference Brands: Xadago (USA/EU)
By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under βFair use.β
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Stay updated on pharma trends and marketplace opportunities.
Online Β· B2B Pharma Β· Medical Tourism Β· NPP